Xeris Pharmaceuticals Stock Options Expiring on 20th of December
| XERS Stock | USD 3.51 0.07 1.96% |
Xeris Pharmaceuticals' latest option contracts expiring on 2024-12-20 are carrying combined implied volatility of 2.49 with a put-to-call open interest ratio of 0.07 over 11 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on 2024-12-20. The total put volume is at 46.0, with calls trading at the volume of 46.0. This yields a 0.31 put-to-call volume ratio.
Open Interest Against 2024-12-20 Option Contracts
Xeris Pharmaceuticals option prices can potentially be used to forecast stock returns because most option chains provide information not only about the current prices but also about the future conditions in Xeris Pharmaceuticals' lending market. For example, when Xeris Pharmaceuticals' puts are not actively trading or completely missing in the marketplace, investors can use it to internalize expected shorting costs. So if an investor is writing a put option on Xeris Pharmaceuticals, he or she must hedge the risk by shorting Xeris Pharmaceuticals stock over its option's life.
2024-12-20
The chart above shows Xeris Pharmaceuticals' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Xeris Pharmaceuticals' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Xeris Pharmaceuticals' option, there is no secondary market available for investors to trade.
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Xeris Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. Xeris Pharmaceuticals In The Money Call Balance
When Xeris Pharmaceuticals' strike price is surpassing the current stock price, the option contract against Xeris Pharmaceuticals stock is said to be in the money. When it comes to buying Xeris Pharmaceuticals' options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Xeris Pharmaceuticals are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
Xeris Current Options Market Mood
Xeris Pharmaceuticals' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Xeris Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Unfortunately, most Xeris Pharmaceuticals' options investors are not very successful. Xeris Pharmaceuticals' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current Xeris contract
Base on the Rule 16, the options market is currently suggesting that Xeris Pharmaceuticals will have an average daily up or down price movement of about 0.16% per day over the life of the 2024-12-20 option contract. With Xeris Pharmaceuticals trading at USD 3.51, that is roughly USD 0.005462. If you think that the market is fully incorporating Xeris Pharmaceuticals' daily price movement you should consider buying Xeris Pharmaceuticals options at the current volatility level of 2.49%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Xeris |
Xeris Pharmaceuticals Option Chain
When Xeris Pharmaceuticals' strike price is surpassing the current stock price, the option contract against Xeris Pharmaceuticals stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Xeris Pharmaceuticals' option chain is a display of a range of information that helps investors for ways to trade options on Xeris. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Xeris. It also shows strike prices and maturity days for a Xeris Pharmaceuticals against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Expiration | Current Spread | Last Price | |||
Call | XERS Option Call 20-12-2024 0 | 69 | 2024-12-20 | 2.6 - 3.5 | 2.9 | In |
Call | XERS Option Call 20-12-2024 1 | 4 | 2024-12-20 | 1.4 - 2.15 | 1.77 | In |
Call | XERS Option Call 20-12-2024 1 | 9 | 2024-12-20 | 1.95 - 2.3 | 1.55 | In |
Call | XERS Option Call 20-12-2024 2 | 1161 | 2024-12-20 | 1.45 - 1.6 | 1.5 | In |
Call | XERS Option Call 20-12-2024 2 | 2789 | 2024-12-20 | 0.9 - 1.1 | 1.25 | In |
Call | XERS Option Call 20-12-2024 5 | 1806 | 2024-12-20 | 0.0 - 0.05 | 0.05 | Out |
Call | XERS Option Call 20-12-2024 7 | 322 | 2024-12-20 | 0.0 - 0.45 | 0.05 | Out |
Put | XERS Option Put 20-12-2024 1 | 19 | 2024-12-20 | 0.0 - 0.0 | 0.3 | Out |
Put | XERS Option Put 20-12-2024 2 | 62 | 2024-12-20 | 0.0 - 0.05 | 0.1 | Out |
Put | XERS Option Put 20-12-2024 2 | 318 | 2024-12-20 | 0.0 - 0.05 | 0.05 | Out |
Put | XERS Option Put 20-12-2024 5 | 4 | 2024-12-20 | 1.4 - 1.55 | 1.7 | In |
Xeris Pharmaceuticals Market Cap Over Time
Market Cap |
| Timeline |
Xeris Total Stockholder Equity
Total Stockholder Equity |
|
Xeris Pharmaceuticals Corporate Management
| PharmD D | Senior Affairs | Profile | |
| Beth JD | Chief Secretary | Profile | |
| Steven Pieper | Chief Officer | Profile | |
| Dr MBA | CoFounder Officer | Profile | |
| Paul JD | Senior Advisor | Profile |
Additional Tools for Xeris Stock Analysis
When running Xeris Pharmaceuticals' price analysis, check to measure Xeris Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Xeris Pharmaceuticals is operating at the current time. Most of Xeris Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Xeris Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Xeris Pharmaceuticals' price. Additionally, you may evaluate how the addition of Xeris Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.